Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis

NCT02123524 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT02123524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02123524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis
Lead sponsor
McMaster University
Phase
Phase 3
Overall status
Completed
Start date
November 11, 2014
Completion date
December 3, 2018
Enrollment
85 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic superficial vein thrombosis